Keywords
Last Name
Institution

Aimee Louise Mcrae-Clark

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
RN 190
125 Doughty St.
Phone843-792-5216
Fax843-792-4817
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Aimee McRae-Clark is a Professor in the Department of Psychiatry and Behavioral Sciences as well as the Department of Neuroscience at the Medical University of South Carolina (MUSC). In addition, she is an adjunct Professor in the South Carolina College of Pharmacy. She received her undergraduate degree in pharmacy from the University of Georgia and her doctorate in pharmacy from MUSC. Dr. McRae-Clark completed a residency in psychiatric pharmacy and two years of a National Institute on Drug Abuse research fellowship. The majority of Dr. McRae-Clark’s research focuses on medication development for substance use disorders, and primarily cannabis and cocaine dependence. In addition, Dr. McRae-Clark has had a long-standing interest in research related to women’s health and has been an integral member of the MUSC Specialized Center of Research (SCOR) on Sex and Gender Factors Affecting Women’s Health since its inception in 2002.

    Collapse keywords
    Substance Use, cannabis use disorders, cocaine use disorders, medication development, gender differences

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sherman BJ, Caruso MA, McRae-Clark AL. Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology. Pharmacol Biochem Behav. 2019 Apr; 179:22-26. PMID: 30711528.
      View in: PubMed
    2. Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 Jan 28; 30:35-41. PMID: 30798020.
      View in: PubMed
    3. Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. Int Rev Psychiatry. 2018 06; 30(3):216-225. PMID: 29956576.
      View in: PubMed
    4. Baker NL, Gray KM, Sherman BJ, Morella K, Sahlem GL, Wagner AM, McRae-Clark AL. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277. PMID: 29698894.
      View in: PubMed
    5. Moreland AD, McRae-Clark A. Parenting outcomes of parenting interventions in integrated substance-use treatment programs: A systematic review. J Subst Abuse Treat. 2018 Jun; 89:52-59. PMID: 29706173.
      View in: PubMed
    6. Chauchard E, Hartwell KJ, McRae-Clark AL, Sherman BJ, Gorelick DA. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder. Prim Care Companion CNS Disord. 2018 Feb 22; 20(1). PMID: 29489073.
      View in: PubMed
    7. Sherman BJ, Baker NL, Squeglia LM, McRae-Clark AL. Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat. 2018 Apr; 87:16-22. PMID: 29471922.
      View in: PubMed
    8. Jiang W, Luo Z, Martin L, Wan Z, Fu P, Wagner A, Ling B, Heath SL, Haque A, McRae-Clark A. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res. 2018; 16(2):143-150. PMID: 29968539.
      View in: PubMed
    9. Bowen LL, McRae-Clark AL. Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies. Pharmacotherapy. 2018 01; 38(1):80-85. PMID: 29178487.
      View in: PubMed
    10. Moran-Santa Maria MM, Sherman BJ, Brady KT, Baker NL, Hyer JM, Ferland C, McRae-Clark AL. Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav. 2018 02; 165:63-69. PMID: 29126857.
      View in: PubMed
    11. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7. PMID: 29112827.
      View in: PubMed
    12. Sahlem GL, Baker NL, George MS, Malcolm RJ, McRae-Clark AL. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55. PMID: 28806104.
      View in: PubMed
    13. Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257. PMID: 28623823.
      View in: PubMed
    14. McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20. PMID: 28511033.
      View in: PubMed
    15. Valles R, McRae-Clark A. The Gap in Leadership Training for Scientists from Underrepresented Groups. Behav Ther (N Y N Y). 2017 Mar; 40(3):80-81. PMID: 30505064.
      View in: PubMed
    16. Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144. PMID: 28152236.
      View in: PubMed
    17. Sherman BJ, Baker NL, McRae-Clark AL. Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention. Psychiatry Res. 2017 Mar; 249:318-320. PMID: 28152465.
      View in: PubMed
    18. McRae-Clark AL, Cason AM, Kohtz AS, Moran Santa-Maria M, Aston-Jones G, Brady KT. Impact of gender on corticotropin-releasing factor and noradrenergic sensitivity in cocaine use disorder. J Neurosci Res. 2017 01 02; 95(1-2):320-327. PMID: 27870396.
      View in: PubMed
    19. Sherman BJ, McRae-Clark AL. Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy. 2016 05; 36(5):511-35. PMID: 27027272.
      View in: PubMed
    20. Sherman BJ, Baker NL, McRae-Clark AL. Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav. 2016 09; 60:197-202. PMID: 27156221.
      View in: PubMed
    21. Moran-Santa Maria MM, Baker NL, McRae-Clark AL, Prisciandaro JJ, Brady KT. Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend. 2016 May 01; 162:56-63. PMID: 26961964.
      View in: PubMed
    22. Allen AM, McRae-Clark AL, Carlson S, Saladin ME, Gray KM, Wetherington CL, McKee SA, Allen SS. Determining menstrual phase in human biobehavioral research: A review with recommendations. Exp Clin Psychopharmacol. 2016 Feb; 24(1):1-11. PMID: 26570992.
      View in: PubMed
    23. Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82. PMID: 26708108.
      View in: PubMed
    24. McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75. PMID: 26685701.
      View in: PubMed
    25. McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37. PMID: 26386827.
      View in: PubMed
    26. Flanagan JC, Baker NL, McRae-Clark AL, Brady KT, Moran-Santa Maria MM. Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence. Psychiatry Res. 2015 Sep 30; 229(1-2):94-100. PMID: 26231584.
      View in: PubMed
    27. McRae-Clark AL, Baker NL, Sonne SC, DeVane CL, Wagner A, Norton J. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence. J Subst Abuse Treat. 2015 Oct; 57:70-4. PMID: 26028133.
      View in: PubMed
    28. Santa Ana EJ, Prisciandaro JJ, Saladin ME, McRae-Clark AL, Shaftman SR, Nietert PJ, Brady KT. D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict. 2015 Apr; 24(3):217-24. PMID: 25808169.
      View in: PubMed
    29. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587.
      View in: PubMed
    30. Moran-Santa Maria MM, Baker NL, Ramakrishnan V, Brady KT, McRae-Clark A. Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):146-52. PMID: 25140866.
      View in: PubMed
    31. Prisciandaro JJ, Joseph JE, Myrick H, McRae-Clark AL, Henderson S, Pfeifer J, Brady KT. The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction. 2014 Dec; 109(12):2062-70. PMID: 24938849.
      View in: PubMed
    32. Moran-Santa Maria MM, McRae-Clark A, Baker NL, Ramakrishnan V, Brady KT. Yohimbine administration and cue-reactivity in cocaine-dependent individuals. Psychopharmacology (Berl). 2014 Oct; 231(21):4157-65. PMID: 24710621.
      View in: PubMed
    33. Prisciandaro JJ, Myrick H, Henderson S, McRae-Clark AL, Brady KT. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):44-9. PMID: 23683790.
      View in: PubMed
    34. McRae-Clark AL, Baker NL, Maria MM, Brady KT. Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology (Berl). 2013 Aug; 228(4):623-31. PMID: 23564179.
      View in: PubMed
    35. Prisciandaro JJ, Myrick H, Henderson S, McRae-Clark AL, Santa Ana EJ, Saladin ME, Brady KT. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):195-201. PMID: 23497788.
      View in: PubMed
    36. Saladin ME, Gray KM, McRae-Clark AL, Larowe SD, Yeatts SD, Baker NL, Hartwell KJ, Brady KT. A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology (Berl). 2013 Apr; 226(4):721-37. PMID: 23460266.
      View in: PubMed
    37. Hartwell KJ, Lematty T, McRae-Clark AL, Gray KM, George MS, Brady KT. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. Am J Drug Alcohol Abuse. 2013 Mar; 39(2):92-8. PMID: 23421569.
      View in: PubMed
    38. Hartwell KJ, Moran-Santa Maria MM, Twal WO, Shaftman S, DeSantis SM, McRae-Clark AL, Brady KT. Association of elevated cytokines with childhood adversity in a sample of healthy adults. J Psychiatr Res. 2013 May; 47(5):604-10. PMID: 23415658.
      View in: PubMed
    39. Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, McRae-Clark AL, Brady KT. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12. PMID: 22706327.
      View in: PubMed
    40. Prisciandaro JJ, Korte JE, McRae-Clark AL, Brady KT. Associations between behavioral disinhibition and cocaine use history in individuals with cocaine dependence. Addict Behav. 2012 Oct; 37(10):1185-8. PMID: 22710029.
      View in: PubMed
    41. Prisciandaro JJ, McRae-Clark AL, Myrick H, Henderson S, Brady KT. Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar; 19(2):240-9. PMID: 22458561.
      View in: PubMed
    42. Saladin ME, Santa Ana EJ, LaRowe SD, Simpson AN, Tolliver BK, Price KL, McRae-Clark AL, Brady KT. Does alexithymia explain variation in cue-elicited craving reported by methamphetamine-dependent individuals? Am J Addict. 2012 Mar-Apr; 21(2):130-5. PMID: 22332856.
      View in: PubMed
    43. Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012 Feb; 25(1):33-41. PMID: 22299805.
      View in: PubMed
    44. Tolliver BK, Price KL, Baker NL, LaRowe SD, Simpson AN, McRae-Clark AL, Saladin ME, DeSantis SM, Chapman E, Garrett M, Brady KT. Impaired cognitive performance in subjects with methamphetamine dependence during exposure to neutral versus methamphetamine-related cues. Am J Drug Alcohol Abuse. 2012 May; 38(3):251-9. PMID: 22257306.
      View in: PubMed
    45. Price KL, Baker NL, McRae-Clark AL, Saladin ME, Desantis SM, Santa Ana EJ, Brady KT. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals. Psychopharmacology (Berl). 2013 Apr; 226(4):739-46. PMID: 22234379.
      View in: PubMed
    46. Hartwell KJ, Back SE, McRae-Clark AL, Shaftman SR, Brady KT. Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Addict Behav. 2012 Apr; 37(4):373-8. PMID: 22284583.
      View in: PubMed
    47. Price KL, DeSantis SM, Simpson AN, Tolliver BK, McRae-Clark AL, Saladin ME, Baker NL, Wagner MT, Brady KT. The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict. 2011 Sep-Oct; 20(5):447-55. PMID: 21838844.
      View in: PubMed
    48. McRae-Clark AL, Carter RE, Price KL, Baker NL, Thomas S, Saladin ME, Giarla K, Nicholas K, Brady KT. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology (Berl). 2011 Nov; 218(1):49-58. PMID: 21710170.
      View in: PubMed
    49. Prisciandaro JJ, McRae-Clark AL, Moran-Santa Maria MM, Hartwell KJ, Brady KT. Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):80-5. PMID: 21306838.
      View in: PubMed
    50. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9. PMID: 20958842.
      View in: PubMed
    51. McRae-Clark AL, Brady KT, Hartwell KJ, White K, Carter RE. Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial. J Atten Disord. 2011 Oct; 15(7):539-44. PMID: 20538968.
      View in: PubMed
    52. Moran-Santa Maria MM, McRae-Clark AL, Back SE, DeSantis SM, Baker NL, Spratt EG, Simpson AN, Brady KT. Influence of cocaine dependence and early life stress on pituitary-adrenal axis responses to CRH and the Trier social stressor. Psychoneuroendocrinology. 2010 Nov; 35(10):1492-500. PMID: 20570051.
      View in: PubMed
    53. Price KL, Saladin ME, Baker NL, Tolliver BK, DeSantis SM, McRae-Clark AL, Brady KT. Extinction of drug cue reactivity in methamphetamine-dependent individuals. Behav Res Ther. 2010 Sep; 48(9):860-5. PMID: 20538262.
      View in: PubMed
    54. Tolliver BK, McRae-Clark AL, Saladin M, Price KL, Simpson AN, DeSantis SM, Baker NL, Brady KT. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):106-13. PMID: 20337507.
      View in: PubMed
    55. Waldrop AE, Price KL, Desantis SM, Simpson AN, Back SE, McRae AL, Spratt EG, Kreek MJ, Brady KT. Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cues. Psychoneuroendocrinology. 2010 Jul; 35(6):798-806. PMID: 20004523.
      View in: PubMed
    56. Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, Baker NL, Spratt E, Kreek MJ, Brady KT. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. 2010 Jan 01; 106(1):21-7. PMID: 19726138.
      View in: PubMed
    57. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, Wahlquist AE, Simpson SA, Brady KT. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8. PMID: 19699593.
      View in: PubMed
    58. Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE, Back SE, Kreek MJ. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry. 2009 Apr; 66(4):422-30. PMID: 19349312.
      View in: PubMed
    59. Price KL, McRae-Clark AL, Saladin ME, Maria MM, DeSantis SM, Back SE, Brady KT. D-cycloserine and cocaine cue reactivity: preliminary findings. Am J Drug Alcohol Abuse. 2009; 35(6):434-8. PMID: 20014913.
      View in: PubMed
    60. Spratt EG, Back SE, Yeatts SD, Simpson AN, McRae-Clark A, Moran-Santa Maria MM, Price KL, Hartwell KT, Brady KT. Relationship between child abuse and adult smoking. Int J Psychiatry Med. 2009; 39(4):417-26. PMID: 20391862.
      View in: PubMed
    61. Tolliver BK, McRae AL, Verduin ML, Anderson SJ, Brady KT. Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series. J Clin Psychopharmacol. 2008 Aug; 28(4):464-7. PMID: 18626281.
      View in: PubMed
    62. Back SE, Waldrop AE, Saladin ME, Yeatts SD, Simpson A, McRae AL, Upadhyaya HP, Contini Sisson R, Spratt EG, Allen J, Kreek MJ, Brady KT. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology. 2008 Jun; 33(5):560-8. PMID: 18321653.
      View in: PubMed
    63. Back SE, Brady KT, Waldrop AE, Yeatts SD, McRae AL, Spratt E. Early life trauma and sensitivity to current life stressors in individuals with and without cocaine dependence. Am J Drug Alcohol Abuse. 2008; 34(4):389-96. PMID: 18584568.
      View in: PubMed
    64. Verduin ML, Payne RA, McRae AL, Back SE, Simpson SA, Sarang RY, Brady KT. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict. 2007 Nov-Dec; 16(6):484-7. PMID: 18058415.
      View in: PubMed
    65. Waldrop AE, Ana EJ, Saladin ME, McRae AL, Brady KT. Differences in early onset alcohol use and heavy drinking among persons with childhood and adulthood trauma. Am J Addict. 2007 Nov-Dec; 16(6):439-42. PMID: 18058407.
      View in: PubMed
    66. Waldrop AE, Back SE, Brady KT, Upadhyaya HP, McRae AL, Saladin ME. Daily stressor sensitivity, abuse effects, and cocaine use in cocaine dependence. Addict Behav. 2007 Dec; 32(12):3015-25. PMID: 17706887.
      View in: PubMed
    67. LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW, Malcolm R. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7. PMID: 17606664.
      View in: PubMed
    68. McRae AL, Hedden SL, Malcolm RJ, Carter RE, Brady KT. Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict Behav. 2007 Jul; 32(7):1433-40. PMID: 17150310.
      View in: PubMed
    69. Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF, Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6. PMID: 16847538.
      View in: PubMed
    70. McRae AL, Brady KT, Carter RE. Buspirone for treatment of marijuana dependence: a pilot study. Am J Addict. 2006 Sep-Oct; 15(5):404. PMID: 16966201.
      View in: PubMed
    71. McRae AL, Saladin ME, Brady KT, Upadhyaya H, Back SE, Timmerman MA. Stress reactivity: biological and subjective responses to the cold pressor and Trier Social stressors. Hum Psychopharmacol. 2006 Aug; 21(6):377-85. PMID: 16915579.
      View in: PubMed
    72. Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME, Randall PK. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46. PMID: 16737451.
      View in: PubMed
    73. Santa Ana EJ, Saladin ME, Back SE, Waldrop AE, Spratt EG, McRae AL, LaRowe SD, Timmerman MA, Upadhyaya H, Brady KT. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma. Psychoneuroendocrinology. 2006 May; 31(4):501-9. PMID: 16413134.
      View in: PubMed
    74. LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, Saladin M, McRae A, Brady K. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10. PMID: 16449100.
      View in: PubMed
    75. McRae AL, Sonne SC, Brady KT, Durkalski V, Palesch Y. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63. PMID: 14766438.
      View in: PubMed
    76. McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6. PMID: 15129422.
      View in: PubMed
    77. McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat. 2003 Jun; 24(4):369-76. PMID: 12867212.
      View in: PubMed
    78. McRae AL. Escitalopram H Lundbeck. Curr Opin Investig Drugs. 2002 Aug; 3(8):1225-9. PMID: 12211420.
      View in: PubMed
    79. McRae AL, Brady KT, Sonne SC. Alcohol and substance abuse. Med Clin North Am. 2001 May; 85(3):779-801. PMID: 11349484.
      View in: PubMed
    80. McRae AL, Brady KT. Review of sertraline and its clinical applications in psychiatric disorders. Expert Opin Pharmacother. 2001 May; 2(5):883-92. PMID: 11336629.
      View in: PubMed
    81. Markowitz JS, McRae AL, Sonne SC. Oral nutritional supplementation for the alcoholic patient: a brief overview. Ann Clin Psychiatry. 2000 Sep; 12(3):153-8. PMID: 10984005.
      View in: PubMed
    Mcrae-Clark's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _